# GeDiPNet Cluster 486 -- Enriched GO Terms (Biological Process) -- generated 2026-10-20 00:01:25
# GO term enrichment: Biological Process terms (gene2go, human/tax_id=9606 only), upper-tail hypergeometric test, fold enrichment = (overlap / cluster gene count) / (term gene count / universe size), Benjamini-Hochberg FDR-corrected. Top 15 terms per cluster by q-value. See scripts/build_cluster_go_enrichment.php on gedipnet.bicnirrh.res.in. Data as of: 2026-10-20 03:23:14.
GO Term	GO ID	Overlap Genes	Overlap Gene Names	Term Gene Count	Cluster Gene Count	Fold Enrichment	P-value	FDR Q-value
regulation of DNA-templated transcription	GO:0006355	8	BRPF1, ASH1L, NFIB, SETD5, MYT1L, ZFHX4, ZMYND8, ZBTB11	1454	21	4.90	1.069e-4	3.249e-3
chromatin organization	GO:0006325	5	BRPF1, ASH1L, SETD5, ZMYND11, ZMYND8	449	21	9.91	1.159e-4	3.442e-3
neuron fate specification	GO:0048665	2	NFIB, MYT1L	24	21	74.15	3.271e-4	7.127e-3
regeneration	GO:0031099	1	NFIB	1	21	889.86	1.124e-3	1.550e-2
lung ciliated cell differentiation	GO:0061141	1	NFIB	1	21	889.86	1.124e-3	1.550e-2
negative regulation of epithelial cell proliferation involved in lung morphogenesis	GO:2000795	1	NFIB	1	21	889.86	1.124e-3	1.550e-2
tarsal gland development	GO:1903699	1	ASH1L	1	21	889.86	1.124e-3	1.550e-2
uterine gland development	GO:1903709	1	ASH1L	1	21	889.86	1.124e-3	1.550e-2
cell differentiation involved in salivary gland development	GO:0060689	1	NFIB	2	21	444.93	2.246e-3	2.244e-2
negative regulation of mesenchymal cell proliferation involved in lung development	GO:2000791	1	NFIB	2	21	444.93	2.246e-3	2.244e-2
selenocysteine biosynthetic process	GO:0016260	1	SEPHS1	2	21	444.93	2.246e-3	2.244e-2
glial cell fate specification	GO:0021780	1	NFIB	3	21	296.62	3.368e-3	2.763e-2
principal sensory nucleus of trigeminal nerve development	GO:0021740	1	NFIB	3	21	296.62	3.368e-3	2.763e-2
positive regulation of MDA-5 signaling pathway	GO:1900245	1	ANKRD17	4	21	222.46	4.488e-3	3.173e-2
negative regulation of transcription by RNA polymerase III	GO:0016480	1	SETD5	4	21	222.46	4.488e-3	3.173e-2